Award
National Cancer Institute 5R01CA283330-03
Bromodomain and extra-terminal motif (BET) inhibitors in Solitary fibrous tumor (SFT)
Recipient
University of Texas Dallas
Award Amount
$399,996.00
Ceiling
$399,996.00
Awarded
April 27, 2026
Identifier
5R01CA283330-03
Award for research on BET inhibitors targeting Solitary fibrous tumors, funded by the National Cancer Institute, focusing on preclinical and clinical trial preparations.
Description
Research on BET inhibitors for Solitary fibrous tumors, including phenotypic assays, molecular mechanism studies, and in vivo safety and efficacy evaluations. Funded by NIH/NCI with aims to initiate a clinical trial.